[EN] NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 δ/&egr; INHIBITORS<br/>[FR] UTILISATION DE NOUVEAUX IMIDAZOLES SUBSTITUÉS COMME INHIBITEURS DE LA CASÉINE KINASE 1 &Dgr;/&Egr;
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2014100533A1
公开(公告)日:2014-06-26
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
这项发明提供了式(I)的化合物及其药学上可接受的盐。式(I)的化合物通过抑制蛋白激酶活性,因此可用作抗癌药物。